[Should the use of gyrase inhibitors be limited to hospitals?].
Shah
P M
PM
Klinikum J.-W.-Goethe-Universität, Frankfurt am Main.
D042462:4-Quinolones; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy; D059005:Topoisomerase II Inhibitors; D014552:Urinary Tract Infections / Q000188:drug therapy
D042462:4-Quinolones; D000890:Anti-Infective Agents; D059005:Topoisomerase II Inhibitors
Sollte der Einsatz von Gyrasehemmern auf das Krankenhaus beschränkt bleiben?